Company intelligence / Profile preview

Safely2Prosperity

Boston, Massachusetts, United Statessafely2prosperity.com ↗

Ownership: Private
Development stage: Commercial

Overview

Safely2Prosperity has developed and commercialized a cloud-based infectious disease risk-management solution that automates workplace immunizations, treatments, testing, quarantines, exposure tracking, and compliance. The system has been deployed in the US and internationally for COVID-19 response. No clinical trial results are relevant as it’s not a drug/device company.

Therapeutic areas: Infectious Diseases
Modalities: Software/SaaS digital health solution
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

In partnership discussions with global systems integrators operating in over fifty countriesEstablished reseller networks in the US, India, Japan

Beyond the preview

Go deeper on Safely2Prosperity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Safely2Prosperity.

Explore the full profile